Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Snx9 | Rat | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | SNX9 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SNX9 mRNA | CTD | PMID:22079256 | Snx9 | Rat | 1,2-dimethylhydrazine | increases expression | ISO | Snx9 (Mus musculus) | 6480464 | 1,2-Dimethylhydrazine results in increased expression of SNX9 mRNA | CTD | PMID:22206623 | Snx9 | Rat | 1-chloro-2,4-dinitrobenzene | increases expression | ISO | SNX9 (Homo sapiens) | 6480464 | Dinitrochlorobenzene results in increased expression of SNX9 mRNA | CTD | PMID:17374397 | Snx9 | Rat | 17alpha-ethynylestradiol | affects expression | ISO | Snx9 (Mus musculus) | 6480464 | Ethinyl Estradiol affects the expression of SNX9 mRNA | CTD | PMID:17555576 | Snx9 | Rat | 17beta-estradiol | decreases expression | ISO | SNX9 (Homo sapiens) | 6480464 | Estradiol results in decreased expression of SNX9 mRNA | CTD | PMID:19167446 | Snx9 | Rat | 2,2',4,4'-Tetrabromodiphenyl ether | decreases expression | ISO | SNX9 (Homo sapiens) | 6480464 | 2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of SNX9 protein | CTD | PMID:31675489 | Snx9 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Snx9 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of SNX9 mRNA | CTD | PMID:21570461 | Snx9 | Rat | 2,4,6-tribromophenol | decreases expression | ISO | SNX9 (Homo sapiens) | 6480464 | 2,4,6-tribromophenol results in decreased expression of SNX9 mRNA | CTD | PMID:31675489 | Snx9 | Rat | 2-hydroxypropanoic acid | decreases expression | ISO | SNX9 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of SNX9 mRNA | CTD | PMID:30851411 | Snx9 | Rat | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | Snx9 (Mus musculus) | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of SNX9 mRNA | CTD | PMID:26251327 | Snx9 | Rat | 4-(ethoxymethylene)-2-phenyloxazol-5-one | increases expression | ISO | SNX9 (Homo sapiens) | 6480464 | Oxazolone results in increased expression of SNX9 mRNA | CTD | PMID:17374397 | Snx9 | Rat | aflatoxin B1 | increases expression | ISO | Snx9 (Mus musculus) | 6480464 | Aflatoxin B1 results in increased expression of SNX9 mRNA | CTD | PMID:19770486 | Snx9 | Rat | arsenite(3-) | multiple interactions | ISO | SNX9 (Homo sapiens) | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to SNX9 mRNA] | CTD | PMID:32406909 | Snx9 | Rat | benzo[a]pyrene | affects methylation | ISO | SNX9 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of SNX9 intron; Benzo(a)pyrene affects the methylation of SNX9 promoter | CTD | PMID:27901495|PMID:30157460 | Snx9 | Rat | benzo[a]pyrene diol epoxide I | decreases expression | ISO | SNX9 (Homo sapiens) | 6480464 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of SNX9 mRNA | CTD | PMID:19150397|PMID:20018196 | Snx9 | Rat | benzoates | increases expression | ISO | SNX9 (Homo sapiens) | 6480464 | Benzoates analog results in increased expression of SNX9 mRNA | CTD | PMID:29472718 | Snx9 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of SNX9 mRNA | CTD | PMID:25181051 | Snx9 | Rat | bisphenol A | increases methylation | ISO | SNX9 (Homo sapiens) | 6480464 | bisphenol A results in increased methylation of SNX9 gene | CTD | PMID:31601247 | Snx9 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of SNX9 mRNA | CTD | PMID:34947998 | Snx9 | Rat | bisphenol A | increases expression | ISO | SNX9 (Homo sapiens) | 6480464 | bisphenol A results in increased expression of SNX9 protein | CTD | PMID:33181973 | Snx9 | Rat | bisphenol A | multiple interactions | ISO | SNX9 (Homo sapiens) | 6480464 | [[ginger extract results in increased abundance of Oils, Volatile] which co-treated with bisphenol A] affects more ... | CTD | PMID:33376534 | Snx9 | Rat | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of SNX9 gene | CTD | PMID:28505145 | Snx9 | Rat | bisphenol AF | increases expression | ISO | SNX9 (Homo sapiens) | 6480464 | bisphenol AF results in increased expression of SNX9 protein | CTD | PMID:34186270 | Snx9 | Rat | Bisphenol B | increases expression | ISO | SNX9 (Homo sapiens) | 6480464 | bisphenol B results in increased expression of SNX9 protein | CTD | PMID:34186270 | Snx9 | Rat | caffeine | increases phosphorylation | ISO | SNX9 (Homo sapiens) | 6480464 | Caffeine results in increased phosphorylation of SNX9 protein | CTD | PMID:35688186 | Snx9 | Rat | calcitriol | increases expression | ISO | SNX9 (Homo sapiens) | 6480464 | Calcitriol results in increased expression of SNX9 mRNA | CTD | PMID:16002434 | Snx9 | Rat | CGP 52608 | multiple interactions | ISO | SNX9 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to SNX9 gene] | CTD | PMID:28238834 | Snx9 | Rat | choline | multiple interactions | ISO | Snx9 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression more ... | CTD | PMID:20938992 | Snx9 | Rat | copper(II) sulfate | increases expression | ISO | SNX9 (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of SNX9 mRNA | CTD | PMID:19549813 | Snx9 | Rat | coumarin | increases phosphorylation | ISO | SNX9 (Homo sapiens) | 6480464 | coumarin results in increased phosphorylation of SNX9 protein | CTD | PMID:35688186 | Snx9 | Rat | coumestrol | multiple interactions | ISO | SNX9 (Homo sapiens) | 6480464 | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SNX9 mRNA | CTD | PMID:19167446 | Snx9 | Rat | coumestrol | decreases expression | ISO | SNX9 (Homo sapiens) | 6480464 | Coumestrol results in decreased expression of SNX9 mRNA | CTD | PMID:19167446 | Snx9 | Rat | crocidolite asbestos | affects expression | ISO | SNX9 (Homo sapiens) | 6480464 | Asbestos, Crocidolite affects the expression of SNX9 mRNA | CTD | PMID:24160326 | Snx9 | Rat | cyclosporin A | increases expression | ISO | Snx9 (Mus musculus) | 6480464 | Cyclosporine results in increased expression of SNX9 mRNA | CTD | PMID:19770486 | Snx9 | Rat | cyclosporin A | increases expression | ISO | SNX9 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of SNX9 mRNA | CTD | PMID:20106945|PMID:25562108 | Snx9 | Rat | dextran sulfate | multiple interactions | ISO | Snx9 (Mus musculus) | 6480464 | Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of SNX9 protein] | CTD | PMID:32272095 | Snx9 | Rat | dextran sulfate | decreases expression | ISO | Snx9 (Mus musculus) | 6480464 | Dextran Sulfate results in decreased expression of SNX9 protein | CTD | PMID:32272095 | Snx9 | Rat | dibutyl phthalate | increases expression | ISO | Snx9 (Mus musculus) | 6480464 | Dibutyl Phthalate results in increased expression of SNX9 mRNA | CTD | PMID:21266533 | Snx9 | Rat | Enterolactone | multiple interactions | ISO | SNX9 (Homo sapiens) | 6480464 | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of SNX9 mRNA | CTD | PMID:19167446 | Snx9 | Rat | erianin | multiple interactions | ISO | Snx9 (Mus musculus) | 6480464 | Erianin inhibits the reaction [Dextran Sulfate results in decreased expression of SNX9 protein] | CTD | PMID:32272095 | Snx9 | Rat | ethanol | decreases expression | EXP | | 6480464 | Ethanol results in decreased expression of SNX9 protein | CTD | PMID:20133374 | Snx9 | Rat | fenthion | increases expression | ISO | Snx9 (Mus musculus) | 6480464 | Fenthion results in increased expression of SNX9 mRNA | CTD | PMID:34813904 | Snx9 | Rat | folic acid | multiple interactions | ISO | Snx9 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression more ... | CTD | PMID:20938992 | Snx9 | Rat | folic acid | decreases expression | ISO | Snx9 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of SNX9 mRNA | CTD | PMID:25629700 | Snx9 | Rat | FR900359 | increases phosphorylation | ISO | SNX9 (Homo sapiens) | 6480464 | FR900359 results in increased phosphorylation of SNX9 protein | CTD | PMID:37730182 | Snx9 | Rat | inulin | multiple interactions | ISO | Snx9 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SNX9 mRNA | CTD | PMID:36331819 | Snx9 | Rat | ivermectin | decreases expression | ISO | SNX9 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of SNX9 protein | CTD | PMID:32959892 | Snx9 | Rat | L-methionine | multiple interactions | ISO | Snx9 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression more ... | CTD | PMID:20938992 | Snx9 | Rat | menadione | affects expression | ISO | SNX9 (Homo sapiens) | 6480464 | Vitamin K 3 affects the expression of SNX9 mRNA | CTD | PMID:20044591 | Snx9 | Rat | methidathion | increases expression | ISO | Snx9 (Mus musculus) | 6480464 | methidathion results in increased expression of SNX9 mRNA | CTD | PMID:34813904 | Snx9 | Rat | nickel sulfate | increases expression | ISO | SNX9 (Homo sapiens) | 6480464 | nickel sulfate results in increased expression of SNX9 mRNA | CTD | PMID:17374397 | Snx9 | Rat | nimesulide | decreases expression | EXP | | 6480464 | nimesulide results in decreased expression of SNX9 mRNA | CTD | PMID:24136188 | Snx9 | Rat | nitrates | multiple interactions | ISO | Snx9 (Mus musculus) | 6480464 | [Particulate Matter results in increased abundance of Nitrates] which results in increased expression of SNX9 more ... | CTD | PMID:35964746 | Snx9 | Rat | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of SNX9 mRNA | CTD | PMID:25729387 | Snx9 | Rat | paracetamol | affects expression | ISO | Snx9 (Mus musculus) | 6480464 | Acetaminophen affects the expression of SNX9 mRNA | CTD | PMID:17562736 | Snx9 | Rat | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of SNX9 mRNA | CTD | PMID:33387578 | Snx9 | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Snx9 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of SNX9 mRNA; [perfluorooctane sulfonic more ... | CTD | PMID:36331819 | Snx9 | Rat | phenobarbital | affects expression | ISO | SNX9 (Homo sapiens) | 6480464 | Phenobarbital affects the expression of SNX9 mRNA | CTD | PMID:19159669 | Snx9 | Rat | pirinixic acid | multiple interactions | ISO | Snx9 (Mus musculus) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in more ... | CTD | PMID:19710929 | Snx9 | Rat | potassium chromate | multiple interactions | ISO | SNX9 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SNX9 mRNA | CTD | PMID:22079256 | Snx9 | Rat | potassium chromate | decreases expression | ISO | SNX9 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of SNX9 mRNA | CTD | PMID:22079256 | Snx9 | Rat | potassium dichromate | increases expression | ISO | SNX9 (Homo sapiens) | 6480464 | Potassium Dichromate results in increased expression of SNX9 protein | CTD | PMID:23718831 | Snx9 | Rat | pyrogallol | increases expression | ISO | Snx9 (Mus musculus) | 6480464 | Pyrogallol results in increased expression of SNX9 mRNA | CTD | PMID:20362636 | Snx9 | Rat | rac-lactic acid | decreases expression | ISO | SNX9 (Homo sapiens) | 6480464 | Lactic Acid results in decreased expression of SNX9 mRNA | CTD | PMID:30851411 | Snx9 | Rat | serpentine asbestos | affects expression | ISO | SNX9 (Homo sapiens) | 6480464 | Asbestos, Serpentine affects the expression of SNX9 mRNA | CTD | PMID:24160326 | Snx9 | Rat | sodium arsenite | increases expression | ISO | SNX9 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of SNX9 mRNA | CTD | PMID:38568856 | Snx9 | Rat | sodium arsenite | increases expression | ISO | Snx9 (Mus musculus) | 6480464 | sodium arsenite results in increased expression of SNX9 mRNA | CTD | PMID:36209798 | Snx9 | Rat | Soman | increases expression | EXP | | 6480464 | Soman results in increased expression of SNX9 mRNA | CTD | PMID:19281266 | Snx9 | Rat | testosterone | affects expression | ISO | Snx9 (Mus musculus) | 6480464 | Testosterone affects the expression of SNX9 mRNA | CTD | PMID:20403060 | Snx9 | Rat | thimerosal | decreases expression | ISO | SNX9 (Homo sapiens) | 6480464 | Thimerosal results in decreased expression of SNX9 mRNA | CTD | PMID:27188386 | Snx9 | Rat | thiram | increases expression | ISO | SNX9 (Homo sapiens) | 6480464 | Thiram results in increased expression of SNX9 mRNA | CTD | PMID:38568856 | Snx9 | Rat | titanium dioxide | decreases methylation | ISO | Snx9 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of SNX9 gene; titanium dioxide results in decreased methylation more ... | CTD | PMID:35295148 | Snx9 | Rat | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of SNX9 mRNA | CTD | PMID:25729387 | Snx9 | Rat | triphenyl phosphate | affects expression | ISO | SNX9 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of SNX9 mRNA | CTD | PMID:37042841 | Snx9 | Rat | urethane | increases expression | ISO | SNX9 (Homo sapiens) | 6480464 | Urethane results in increased expression of SNX9 mRNA | CTD | PMID:28818685 | Snx9 | Rat | valproic acid | decreases methylation | ISO | SNX9 (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of SNX9 gene | CTD | PMID:29154799 | Snx9 | Rat | valproic acid | decreases expression | ISO | SNX9 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of SNX9 mRNA | CTD | PMID:23179753 | Snx9 | Rat | valproic acid | affects expression | ISO | SNX9 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of SNX9 mRNA | CTD | PMID:25979313 | Snx9 | Rat | vorinostat | decreases expression | ISO | SNX9 (Homo sapiens) | 6480464 | vorinostat results in decreased expression of SNX9 mRNA | CTD | PMID:27188386 | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















